Literature DB >> 25997033

Identification of a novel cellular target and a co-factor for norovirus infection - B cells & commensal bacteria.

Stephanie M Karst1.   

Abstract

Human noroviruses are a leading cause of gastroenteritis worldwide but research on these important enteric pathogens has long been restricted by their uncultivability. Extensive efforts to infect intestinal epithelial cells with murine and human noroviruses in vitro have been thus far unsuccessful while murine noroviruses efficiently and lytically infect innate immune cells including macrophages and dendritic cells. We have recently discovered that murine and human noroviruses infect B cells in vitro. The nature of B cell infection was distinct from innate immune cell infection in that mature B cells were infected noncytopathically in contrast to the lytic infection of macrophages and dendritic cells. Human norovirus infection of B cells was facilitated by commensal bacteria expressing an appropriate histo-blood group antigen. Importantly, we used the mouse model of norovirus infection to confirm that Peyer's patch B cells are infected, and that commensal bacteria stimulate infection, in vivo.

Entities:  

Keywords:  enteric virus; histo-blood group antigen; intestinal microbiota; norovirus

Mesh:

Year:  2015        PMID: 25997033      PMCID: PMC4615308          DOI: 10.1080/19490976.2015.1052211

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  49 in total

1.  Novel type of murine B-cell lymphoma.

Authors:  L L Lanier; M Lynes; G Haughton; P J Wettstein
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

2.  Histo-blood group antigen-like substances of human enteric bacteria as specific adsorbents for human noroviruses.

Authors:  Takayuki Miura; Daisuke Sano; Atsushi Suenaga; Takeshi Yoshimura; Miyu Fuzawa; Toyoko Nakagomi; Osamu Nakagomi; Satoshi Okabe
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

3.  Establishment and characterization of BALB/c lymphoma lines with B cell properties.

Authors:  K J Kim; C Kanellopoulos-Langevin; R M Merwin; D H Sachs; R Asofsky
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

4.  Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Authors:  Timothy J Nice; Megan T Baldridge; Broc T McCune; Jason M Norman; Helen M Lazear; Maxim Artyomov; Michael S Diamond; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

5.  Enteric bacteria promote human and mouse norovirus infection of B cells.

Authors:  Melissa K Jones; Makiko Watanabe; Shu Zhu; Christina L Graves; Lisa R Keyes; Katrina R Grau; Mariam B Gonzalez-Hernandez; Nicole M Iovine; Christiane E Wobus; Jan Vinjé; Scott A Tibbetts; Shannon M Wallet; Stephanie M Karst
Journal:  Science       Date:  2014-11-07       Impact factor: 47.728

6.  Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults.

Authors:  P C Johnson; J J Mathewson; H L DuPont; H B Greenberg
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

7.  Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus.

Authors:  Christopher M Robinson; Palmy R Jesudhasan; Julie K Pfeiffer
Journal:  Cell Host Microbe       Date:  2014-01-15       Impact factor: 21.023

8.  Recombination within the pandemic norovirus GII.4 lineage.

Authors:  John-Sebastian Eden; Mark M Tanaka; Maciej F Boni; William D Rawlinson; Peter A White
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

9.  An enteric virus can replace the beneficial function of commensal bacteria.

Authors:  Elisabeth Kernbauer; Yi Ding; Ken Cadwell
Journal:  Nature       Date:  2014-11-19       Impact factor: 49.962

10.  Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals.

Authors:  Severine Marionneau; Nathalie Ruvoën; Beatrice Le Moullac-Vaidye; Monique Clement; Anne Cailleau-Thomas; Guillermo Ruiz-Palacois; Pengwei Huang; Xi Jiang; Jacques Le Pendu
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

View more
  16 in total

1.  Human norovirus culture in B cells.

Authors:  Melissa K Jones; Katrina R Grau; Veronica Costantini; Abimbola O Kolawole; Miranda de Graaf; Pamela Freiden; Christina L Graves; Marion Koopmans; Shannon M Wallet; Scott A Tibbetts; Stacey Schultz-Cherry; Christiane E Wobus; Jan Vinjé; Stephanie M Karst
Journal:  Nat Protoc       Date:  2015-10-29       Impact factor: 13.491

Review 2.  Prospects and Challenges in the Development of a Norovirus Vaccine.

Authors:  Nicolas W Cortes-Penfield; Sasirekha Ramani; Mary K Estes; Robert L Atmar
Journal:  Clin Ther       Date:  2017-07-26       Impact factor: 3.393

3.  Methods for ascertaining norovirus disease burdens.

Authors:  David J Allen; John P Harris
Journal:  Hum Vaccin Immunother       Date:  2017-11-02       Impact factor: 3.452

4.  Structure-guided design, synthesis and evaluation of oxazolidinone-based inhibitors of norovirus 3CL protease.

Authors:  Vishnu C Damalanka; Yunjeong Kim; Anushka C Galasiti Kankanamalage; Athri D Rathnayake; Nurjahan Mehzabeen; Kevin P Battaile; Scott Lovell; Harry Nhat Nguyen; Gerald H Lushington; Kyeong-Ok Chang; William C Groutas
Journal:  Eur J Med Chem       Date:  2017-12-06       Impact factor: 6.514

Review 5.  The influence of commensal bacteria on infection with enteric viruses.

Authors:  Stephanie M Karst
Journal:  Nat Rev Microbiol       Date:  2016-02-08       Impact factor: 60.633

Review 6.  Recent Advances in the Discovery of Norovirus Therapeutics.

Authors:  Yunjeong Kim; Anushka C Galasiti Kankanamalage; Kyeong-Ok Chang; William C Groutas
Journal:  J Med Chem       Date:  2015-08-17       Impact factor: 7.446

Review 7.  Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens.

Authors:  Eunüs S Ali; Harinda Rajapaksha; Jillian M Carr; Nikolai Petrovsky
Journal:  Antiviral Res       Date:  2016-07-13       Impact factor: 5.970

Review 8.  Recent advances in understanding norovirus pathogenesis.

Authors:  Stephanie M Karst; Scott A Tibbetts
Journal:  J Med Virol       Date:  2016-05-05       Impact factor: 2.327

Review 9.  Interactions between Enteric Bacteria and Eukaryotic Viruses Impact the Outcome of Infection.

Authors:  Angela K Berger; Bernardo A Mainou
Journal:  Viruses       Date:  2018-01-03       Impact factor: 5.048

10.  Norovirus antagonism of B-cell antigen presentation results in impaired control of acute infection.

Authors:  S Zhu; M K Jones; D Hickman; S Han; W Reeves; S M Karst
Journal:  Mucosal Immunol       Date:  2016-03-23       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.